These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24544426)

  • 21. The action of antibiotic combinations on pathogenic staphylococci in vitro.
    MANTEN A
    Antibiot Chemother (Northfield); 1956 Aug; 6(8):480-6. PubMed ID: 24544085
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the in vitro effectiveness of kanamycin and nine other antibiotics against staphylococci.
    GRIFFITH LJ; OSTRANDER WE
    Antibiot Chemother (Northfield); 1959 Jul; 9(7):416-8. PubMed ID: 24545275
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-staphylococcal activity of novobiocin].
    Chabbert Y; Berrod J; Henoch H; Dumas J
    Presse Med (1893); 1958 May; 66(36):809 passim. PubMed ID: 13567446
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro antagonism between erythromycin and spiramycin].
    CHABBERT Y
    Ann Inst Pasteur (Paris); 1956 Jun; 90(6):787-90. PubMed ID: 13340322
    [No Abstract]   [Full Text] [Related]  

  • 25. [Virulence of drug-resistant strains of staphylococci isolated from infected patients].
    PORSHTER KhK
    Antibiotiki (Mosc); 1958; 3(6):95-9. PubMed ID: 24545176
    [No Abstract]   [Full Text] [Related]  

  • 26. NEW ANTIBIOTICS in the fight against resistant staphylococci.
    Am J Pharm Sci Support Public Health; 1956 Sep; 128(9):300-4. PubMed ID: 13372757
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of the in vitro and in vivo effects of erythromycin, penicillin, and oxytetracycline against resistant staphylococci.
    STONE RL; BONIECE WS; CULBERTSON CG
    Antibiot Chemother (Northfield); 1955 Oct; 5(10):574-81. PubMed ID: 24543773
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro activity of spiramycin in combination with tetracycline, erythromycin, penicillin, streptomycin, on Staphylococcus aureus multiplication, studied by microbiophotometer].
    Mathieu N; Faguet M
    Ann Inst Pasteur (Paris); 1958 Jan; 94(1):69-77. PubMed ID: 13509310
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sensitivity of Staphylococcus aureus in vitro to erythromycin, oleandomycin triacetate and novobiocin in suppurative surgical diseases].
    DOLEZALOWA M; ZASOWSKI A
    Pol Przegl Chir; 1962 Feb; 34():131-6. PubMed ID: 13887010
    [No Abstract]   [Full Text] [Related]  

  • 30. [Conclusions drawn from in vitro studies on the pathogenicity of antibiotic resistant and sensitive Micrococcus pyogenes aureus strains cultivated from the excreta of tuberculotic patients].
    HAMPEL M
    Tuberkulozis; 1957; 10(7-9):204-5. PubMed ID: 13530260
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic combinations; antistreptococcal and antistaphylococcal activity of plasma of normal subjects after oral doses of penicillin, oleandomycin and combinations of these antibiotics.
    FINLAND M; JONES WF
    N Engl J Med; 1957 Jan; 256(3):115-9. PubMed ID: 13388042
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the incidence and distribution of antibiotic-resistant Staphylococci.
    HINTON NA; ORR JH
    J Lab Clin Med; 1957 Apr; 49(4):566-72. PubMed ID: 13406392
    [No Abstract]   [Full Text] [Related]  

  • 33. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin, and spiramycin.
    LOWBURY EJ; HURST L
    J Clin Pathol; 1959 Mar; 12(2):163-9. PubMed ID: 13641436
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy for Staphylococcus aureus; combined use of novobiocin and erythromycin and other methods in the treatment of burns.
    LOWBURY EJ
    Lancet; 1957 Aug; 273(6990):305-10. PubMed ID: 13507637
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rapid appearance of cutaneous strains of staphylococci resistant to many antibiotics].
    DELMOTTE A
    Arch Belg Dermatol Syphiligr; 1956 Mar; 11(3-4):336-7. PubMed ID: 13341022
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity against Micrococcus pyogenes of various combinations of antimicrobial agents.
    WAISBREN BA
    J Lab Clin Med; 1955 Oct; 46(4):583-91. PubMed ID: 13263739
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial Resistance Patterns of the Gram-positive Bacteria Isolated from Children with Bloodstream Infection in an Iranian Referral Hospital: A 6-year Study.
    Pourakbari B; Mahmoudi S; Moradzadeh M; Mahzari M; Ashtiani MTH; Tanzifi P; Mamishi S
    Infect Disord Drug Targets; 2018; 18(2):136-144. PubMed ID: 28828970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of pathogenic staphylococci by phagocytes.
    TOMPSETT R
    Trans Assoc Am Physicians; 1956; 69():84-92. PubMed ID: 13380949
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibiotics susceptibility of Streptococcus and Enterococcus: data of Onerba network].
    Vachée A; Varon E; Jouy E; Meunier D;
    Pathol Biol (Paris); 2009 May; 57(3):240-4. PubMed ID: 18343047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and epidemiologic significance of staphylococci resistant to antibiotics].
    LIEBESNY P
    Klin Med Osterr Z Wiss Prakt Med; 1955 Dec; 10(12):537-43. PubMed ID: 13286967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.